Pfizer

DVS Sciences raises $14 million, largest round in Canada life sciences, to expand CyTOF sales

Monday, August 29, 2011 08:00 AM

DVS Sciences, which invented and manufactures an instrument enabling biomarker analysis for scientific research, clinical trials and personalized medicine, has raised $14.6 million in series A financing. This is the largest venture-backed series A equity raised in Canada’s life sciences and medical technology fields in recent years, and is almost twice the average series A funding in the U.S., the company said.

More... »

Amgen to create hundreds of jobs in Dublin

Tuesday, August 23, 2011 10:26 AM

US drug firm Amgen plans to create 100 high-tech jobs at a new factory in Dublin just months after it saved 280 jobs by taking over a Pfizer plant that was earmarked for closure, according to The Post.

More... »

Ampio names chief business officer

Monday, August 22, 2011 12:50 PM

Ampio Pharmaceuticals has named Deborah Knobelman, Ph.D., chief business officer reporting directly to Ampio CEO, Don Wingerter.

More... »

CROs using backlog numbers to put positive spin on less-than-stellar quarterly earnings reports

Monday, August 22, 2011 08:00 AM

Using backlog allows CROs to put a positive spin on what otherwise might be less-than-stellar earnings; while they may not have had the healthiest quarter—or year—financially, they can showcase all of the work that has been promised over the next few quarters in millions, or billions, of dollars.

More... »

Creabilis expands management team

Thursday, August 18, 2011 10:52 AM

Creabilis has expanded its senior management team. Alex Leech joins as vice president, head of finance and operations, James Sandy as senior vice president, head of development, and Peter Spargo as senior vice president of chemistry manufacturing and controls.

More... »

Genelux names Mackey to board of directors

Tuesday, August 16, 2011 10:01 AM

Genelux, a privately held clinical stage biopharmaceutical company, has named Dr. Catherine J. Mackey to its board of directors.

More... »

CTTI report recommends risk-based monitoring

Monday, August 15, 2011 08:02 AM

Almost 90% of those conducting clinical trials within the commercial drug industry always perform on-site visits to their study sites. In contrast, about a third of academic, government or cooperative groups involved in research do. And yet, neither monitoring method is based on any evidence that it improves the quality of the data, as no such evidence yet exists.

More... »

Tornoe joins Exagen Diagnostics

Wednesday, August 10, 2011 11:09 AM

Exagen Diagnostics has named Eric Tornoe its president and chief operating officer.

More... »

Pfizer, UCSD sign potential $50 million research agreement

Monday, August 8, 2011 01:15 PM

In an innovative collaboration designed to speed the process of drug discovery, Pfizer and the University of California, San Diego health sciences report that UC San Diego has joined the ranks of other life science research institutions across the country as part of Pfizer's Centers for Therapeutic Innovation (CTI).

More... »

Pfizer backs out of pact with Biotica

Thursday, August 4, 2011 11:12 AM

Pfizer has returned the rights to a rapamycin analogue program it has been running to explore the potential of diseases such as multiple sclerosis and lupus to the UK's Biotica Technology, according to PharmaTimes.

More... »